These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36606721)

  • 1. Ability of Azathiacyclen Ligands To Stop Cu(Aβ)-Induced Production of Reactive Oxygen Species: [3N1S] Is the Right Donor Set.
    Malikidogo KP; Drommi M; Atrián-Blasco E; Hormann J; Kulak N; Esmieu C; Hureau C
    Chemistry; 2023 Mar; 29(14):e202203667. PubMed ID: 36606721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.
    Rulmont C; Stigliani JL; Hureau C; Esmieu C
    Inorg Chem; 2024 Feb; 63(5):2340-2351. PubMed ID: 38243896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer's-Related Aβ Peptide.
    Gonzalez P; Sabater L; Mathieu E; Faller P; Hureau C
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected Trends in Copper Removal from Aβ Peptide: When Less Ligand Is Better and Zn Helps.
    Esmieu C; Balderrama-Martínez-Sotomayor R; Conte-Daban A; Iranzo O; Hureau C
    Inorg Chem; 2021 Jan; 60(2):1248-1256. PubMed ID: 33400522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new water-soluble Cu(II) chelator that retrieves Cu from Cu(amyloid-β) species, stops associated ROS production and prevents Cu(II)-induced Aβ aggregation.
    Noël S; Perez F; Pedersen JT; Alies B; Ladeira S; Sayen S; Guillon E; Gras E; Hureau C
    J Inorg Biochem; 2012 Dec; 117():322-5. PubMed ID: 22819647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Trishistidine Pseudopeptide with Ability to Remove Both Cu
    Conte-Daban A; Boff B; Candido Matias A; Aparicio CNM; Gateau C; Lebrun C; Cerchiaro G; Kieffer I; Sayen S; Guillon E; Delangle P; Hureau C
    Chemistry; 2017 Dec; 23(67):17078-17088. PubMed ID: 28846165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.
    Drommi M; Rulmont C; Esmieu C; Hureau C
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.
    Esmieu C; Guettas D; Conte-Daban A; Sabater L; Faller P; Hureau C
    Inorg Chem; 2019 Oct; 58(20):13509-13527. PubMed ID: 31247877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.
    Atrián-Blasco E; Conte-Daban A; Hureau C
    Dalton Trans; 2017 Oct; 46(38):12750-12759. PubMed ID: 28937157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
    La Penna G; Hureau C; Andreussi O; Faller P
    J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Water-Soluble Peptoid Chelator that Can Remove Cu
    Behar AE; Sabater L; Baskin M; Hureau C; Maayan G
    Angew Chem Int Ed Engl; 2021 Nov; 60(46):24588-24597. PubMed ID: 34510664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
    Conte-Daban A; Day A; Faller P; Hureau C
    Dalton Trans; 2016 Oct; 45(39):15671-15678. PubMed ID: 27711738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
    da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
    Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.
    Chassaing S; Collin F; Dorlet P; Gout J; Hureau C; Faller P
    Curr Top Med Chem; 2012; 12(22):2573-95. PubMed ID: 23339309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
    Nadal RC; Rigby SE; Viles JH
    Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
    Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
    Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.
    Jiang D; Li X; Liu L; Yagnik GB; Zhou F
    J Phys Chem B; 2010 Apr; 114(14):4896-903. PubMed ID: 20302320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.
    Parthasarathy S; Yoo B; McElheny D; Tay W; Ishii Y
    J Biol Chem; 2014 Apr; 289(14):9998-10010. PubMed ID: 24523414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.